New potential regulators of uterine leiomyomata from DNA arrays: The ionotropic glutamate receptor GluR2

Biochemical and Biophysical Research Communications

Volumn 312, Issue 1, 2003, Pages 249-254

  Tsibris, John C M ^a   Maas, Stefan ^b   Segars, James H ^c   Nicosia, Santo V ^d   Enkemann, Steven A ^e   O'Brien, William F ^a   Spellacy, William N ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^d UNIVERSITY OF SOUTH FLORIDA   (United States)

^e H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

AMPA receptors; Arrays; Glutamate receptors; Leiomyoma; Myometrium; Neovascularization; Uterine neoplasms

Indexed keywords

CALCIUM ION; CATION CHANNEL; DNA; ESTRADIOL; IONOTROPIC RECEPTOR; ISOPROTEIN; LIGAND; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN SUBUNIT; RETINOIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM TRANSPORT; CONTROLLED STUDY; DNA MICROARRAY; ENDOTHELIUM CELL; FEMALE; GUINEA PIG; HUMAN; HUMAN TISSUE; LEIOMYOMA; MYOMETRIUM; NONHUMAN; PERMEABILITY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REGULATORY MECHANISM; TUMOR GROWTH; UPREGULATION; UTERUS TUMOR;

CAVIA PORCELLUS; SUS SCROFA;

EID: 0344395046     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2003.09.189     Document Type: Article

References (42)

1. Schwartz S.M. Epidemiology of uterine leiomyomata. Clin. Obstet. Gynecol. 44:2001;316-326.
2. Weaver F., Hynes D., Goldberg J.M., Khuri S., Daley J., Henderson W. Hysterectomy in Veterans Affairs Medical Centers. Obstet. Gynecol. 97:2001;880-884.
3. DeWaay D.J., Syrop C.H., Nygaard I.E., Davis W.A., Van Voorhis B.J. Natural history of uterine polyps and leiomyomata. Obstet. Gynecol. 100:2002;3-7.
4. Marshall L.M., Spiegelman D., Manson J.E., Goldman M.B., Barbieri R.L., Stampfer M.J., Willett W.C., Hunter D.J. Risk of uterine leiomyomata among premenopausal women in relation to body size and cigarette smoking. Epidemiology. 9:1998;511-517.
5. Faerstein E., Szklo M., Rosenshein N. Risk factors for uterine leiomyoma: a practice-based case-control study. I. African-American heritage, reproductive history, body size, and smoking. Am. J. Epidemiol. 153:2001;1-10.
6. Launonen V., Vierimaa O., Kiuru M., Isola J., Roth S., Pukkala E., Sistonen P., Herva R., Aaltonen L.A. Inherited susceptibility to uterine leiomyomas and renal cell cancer. Proc. Natl. Acad. Sci. USA. 98:2001;3387-3392.
7. Hennig Y., Deichert U., Bonk U., Thode B., Bartnitzke S., Bullerdiek J. Chromosomal translocations affecting 12q14-15 but not deletions of the long arm of chromosome 7 associated with a growth advantage of uterine smooth muscle cells. Mol. Hum. Reprod. 5:1999;1150-1154.
8. Ligon A.H., Morton C.C. Leiomyomata: heritability and cytogenetic studies. Hum. Reprod. Update. 7:2001;8-14.
9. Shozu M., Sumitani H., Segawa T., Yang H.J., Murakami K., Kasai T., Inoue M. Overexpression of aromatase P450 in leiomyoma tissue is driven primarily through promoter I.4 of the aromatase P450 gene (CYP19). J. Clin. Endocrinol. Metab. 87:2002;2540-2548.
10. Reinsch R.C., Murphy A.A., Morales A.J., Yen S.S. The effects of RU 486 and leuprolide acetate on uterine artery blood flow in the fibroid uterus: a prospective, randomized study. Am. J. Obstet. Gynecol. 170:1994;1623-1627. discussion 1627-1628.
11. Tsibris J.C., Porter K.B., Jazayeri A., Tzimas G., Nau H., Huang H., Kuparadze K., Porter G.W., O'Brien W.F., Spellacy W.N. Human uterine leiomyomata express higher levels of peroxisome proliferator-activated receptor gamma, retinoid X receptor alpha, and all-trans retinoic acid than myometrium. Cancer Res. 59:1999;5737-5744.
12. Tsibris J.C., Segars J., Coppola D., Mane S., Wilbanks G.D., O'Brien W.F., Spellacy W.N. Insights from gene arrays on the development and growth regulation of uterine leiomyomata. Fertil. Steril. 78:2002;114-121.
13. Tsibris J.C., Cazenave C.R., Cantor B., Notelovitz M., Kalra P.S., Spellacy W.N. Distribution of cytoplasmic estrogen and progesterone receptors in human endometrium. Am. J. Obstet. Gynecol. 132:1978;449-454.
14. Tsibris J.C., Segars J., Enkemann S., Coppola D., Wilbanks G.D., O'Brien W.F., Spellacy W.N. New and old regulators of uterine leiomyoma growth from screening with DNA arrays. Fertil. Steril. 80:2003;279-281.
15. Walocha J.A., Litwin J.A., Miodonski A.J. Vascular system of intramural leiomyomata revealed by corrosion casting and scanning electron microscopy. Hum. Reprod. 18:2003;1088-1093.
16. Casey R., Rogers P.A., Vollenhoven B.J. An immunohistochemical analysis of fibroid vasculature. Hum. Reprod. 15:2000;1469-1475.
17. Song I., Huganir R.L. Regulation of AMPA receptors during synaptic plasticity. Trends Neurosci. 25:2002;578-588.
18. Seeburg P.H., Higuchi M., Sprengel R. RNA editing of brain glutamate receptor channels: mechanism and physiology. Brain Res. Brain Res. Rev. 26:1998;217-229.
19. Maas S., Rich A., Nishikura K. A-to-I RNA editing: recent news and residual mysteries. J. Biol. Chem. 278:2003;1391-1394.
20. Maas S., Patt S., Schrey M., Rich A. Underediting of glutamate receptor GluR-B mRNA in malignant gliomas. Proc. Natl. Acad. Sci. USA. 98:2001;14687-14692.
21. Gindler E.M., King J.D. Rapid colorimetric determination of calcium in biologic fluids with methylthymol blue. Am. J. Clin. Pathol. 58:1972;376-382.
22. Nowak R.A. Identification of new therapies for leiomyomas: what in vitro studies can tell us. Clin. Obstet. Gynecol. 44:2001;327-334.
23. Gargett C.E., Bucak K., Zaitseva M., Chu S., Taylor N., Fuller P.J., Rogers P.A. Estrogen receptor-alpha and -beta expression in microvascular endothelial cells and smooth muscle cells of myometrium and leiomyoma. Mol. Hum. Reprod. 8:2002;770-775.
24. Hayashi T., Umemori H., Mishina M., Yamamoto T. The AMPA receptor interacts with and signals through the protein tyrosine kinase Lyn. Nature. 397:1999;72-76.
25. Brene S., Messer C., Okado H., Hartley M., Heinemann S.F., Nestler E.J. Regulation of GluR2 promoter activity by neurotrophic factors via a neuron-restrictive silencer element. Eur. J. Neurosci. 12:2000;1525-1533.
26. Verdoorn T.A., Burnashev N., Monyer H., Seeburg P.H., Sakmann B. Structural determinants of ion flow through recombinant glutamate receptor channels. Science. 252:1991;1715-1718.
27. Burnashev N., Monyer H., Seeburg P.H., Sakmann B. Divalent ion permeability of AMPA receptor channels is dominated by the edited form of a single subunit. Neuron. 8:1992;189-198.
28. Piccini A., Malinow R. Critical postsynaptic density 95/disc large/ zonula occludens-1 interactions by glutamate receptor 1 (GluR1) and GluR2 required at different subcellular sites. J. Neurosci. 22:2002;5387-5392.
29. Zhang Q., Fan J.S., Zhang M. Interdomain chaperoning between PSD-95, Dlg, and Zo-1 (PDZ) domains of glutamate receptor-interacting proteins. J. Biol. Chem. 276:2001;43216-43220.
30. Hung A.Y., Sheng M. PDZ domains: structural modules for protein complex assembly. J. Biol. Chem. 277:2002;5699-5702.
31. Patton A.M., Kassis J., Doong H., Kohn E.C. Calcium as a molecular target in angiogenesis. Curr. Pharm. Des. 9:2003;543-551.
32. Gentry C.C., Okolo S.O., Fong L.F., Crow J.C., Maclean A.B., Perrett C.W. Quantification of vascular endothelial growth factor-A in leiomyomas and adjacent myometrium. Clin. Sci. (Lond.). 101:2001;691-695.
33. Fayed Y.M., Tsibris J.C., Langenberg P.W., Robertson A.L. Jr. Human uterine leiomyoma cells: binding and growth responses to epidermal growth factor, platelet-derived growth factor, and insulin. Lab. Invest. 60:1989;30-37.
34. Numasaki M., Fukushi J., Ono M., Narula S.K., Zavodny P.J., Kudo T., Robbins P.D., Tahara H., Lotze M.T. Interleukin-17 promotes angiogenesis and tumor growth. Blood. 101:2003;2620-2627.
35. Skubitz K.M., Skubitz A.P. Differential gene expression in uterine leiomyoma. J. Lab. Clin. Med. 141:2003;297-308.
36. K. Politi, M. Szabolcs, P. Fisher, A. Kljuic, T. Ludwig, A. Efstratiadis, A mouse model of uterine leiomyosarcoma, Am. J. Pathol., in press.
37. Rashid K.A., Hevi S., Chen Y., Le Caherec F., Chuck S.L. A proteomic approach identifies proteins in hepatocytes that bind nascent apolipoprotein B. J. Biol. Chem. 277:2002;22010-22017.
38. Gill S.S., Pulido O.M. Glutamate receptors in peripheral tissues: current knowledge, future research, and implications for toxicology. Toxicol. Pathol. 29:2001;208-223.
39. Rzeski W., Turski L., Ikonomidou C. Glutamate antagonists limit tumor growth. Proc. Natl. Acad. Sci. USA. 98:2001;6372-6377.
40. Jin R., Gouaux E. Probing the function, conformational plasticity, and dimer-dimer contacts of the GluR2 ligand-binding core: studies of 5-substituted Willardiines and GluR2 S1S2 in the crystal. Biochemistry. 42:2003;5201-5213.
41. Ghersi C., Bonfanti A., Manzari B., Feligioni M., Raiteri M., Pittaluga A. Pharmacological heterogeneity of release-regulating presynaptic AMPA/kainate receptors in the rat brain: study with receptor antagonists. Neurochem. Int. 42:2003;283-292.
42. Olive D.L. Role of progesterone antagonists and new selective progesterone receptor modulators in reproductive health. Obstet. Gynecol. Surv. 57:2002;S55-S63.